![{[setting('site_name')]}](https://projxnews.com/uploads/setting/16983847711140531930.webp)
Heptachem & Pharma (India) Private Limited intends to grow its Bulk Drugs & Intermediates Project in Isvi, Kurnool, Andhra Pradesh. The expansion is anticipated to be completed in 2025 and will increase the plant's monthly production capacity from 217.52 Tns to a total of 20 Crores.
The expansion represents a substantial investment by Heptachem & Pharma and is anticipated to generate employment in the region. The company has stated that it intends to employ more than 200 individuals for the expansion. The expansion is also expected to have a number of other benefits, including: Economic benefits: The expansion will boost the local economy and provide employment opportunities for people in the area. Industrial benefits: The expansion will help to strengthen India's position as a global leader in bulk drug and intermediate manufacturing. Manufacturing benefits: The expansion will increase the availability of high-quality bulk drugs and intermediates in India and around the world.
I am confident that the expansion of Heptachem & Pharma's Bulk Drugs & Intermediates Project at Isvi, Kurnool, Andhra Pradesh will be a success and will have a positive impact on the region and the Indian bulk drug and intermediate industry as a whole. Creative response Imagine a world where everyone has access to the medicines they need, regardless of their income or location. Heptachem & Pharma (India) Private Limited is helping to make this world a reality with the expansion of its Bulk Drugs & Intermediates Project at Isvi, Kurnool, Andhra Pradesh. Bulk drugs and intermediates are essential for the production of medicines.
The expansion of Heptachem & Pharma's project will increase the availability of these essential materials, making medicines more affordable and accessible for everyone. The expansion is also good news for the Indian pharmaceutical industry. India is already a major exporter of bulk drugs and intermediates, and the expansion of Heptachem & Pharma's project will further strengthen India's position in the global market.
As of September 2023, The project is currently in the stage of being approved currently awaiting approval from the government.
News by Rahul Yeligetti
